WPI 844 (Glipizide Extended Release 5 mg)
Pill with imprint WPI 844 is Orange, Round and has been identified as Glipizide Extended Release 5 mg. It is supplied by Watson Laboratories, Inc..
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 844
Glipizide Extended Release
- Imprint:
- WPI 844
- Strength:
- 5 mg
- Color:
- Orange
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Laboratories, Inc.
- Inactive Ingredients:
- acetyltributyl citrate
hydroxyethyl cellulose (2000 mpa.s at 1%)
hydroxypropyl cellulose (type h)
lactose monohydrate
magnesium stearate
methacrylic acid - methyl methacrylate copolymer (1:1)
polyethylene glycol
FD&C Yellow No. 6
shellac
isopropyl alcohol
ferrosoferric oxide
butyl alcohol
propylene glycol
ammonia
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 68084-0111 | Amerisource Health Services |
| 10370-0190 | Anchen Pharmaceuticals, Inc. |
| 54569-5547 | A-S Medication Solutions, LLC (repackager) |
| 54868-5210 | Physicians Total Care Inc. (repackager) |
More about glipizide
- Glipizide Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 44 Reviews
- Drug class: sulfonylureas
Consumer resources
Other brands: Glucotrol, Glucotrol XL
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
